591
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Analysis of enhancement at small and large radiation doses for effectiveness of inactivation in cultured cells by combining two agents with radiation

, , &
Pages 521-526 | Received 15 Dec 2015, Accepted 23 May 2016, Published online: 15 Aug 2016

References

  • Barendsen GW, Van Bree C, Franken NA. 2001. Importance of cell proliferative state and potentially lethal damage repair on radiation effectiveness: implications for combined tumor treatments (review). Int J Oncol. 19:247–256.
  • Barendsen GW. 1994. RBE-LET relationships for different types of lethal radiation damage in mammalian cells: comparison with DNA dsb and an interpretation of differences in radiosensitivity. Int J Radiat Biol. 66:433–436.
  • Bergs JW, Franken NA, Haveman J, Geijsen ED, Crezee J, van Bree C. 2007. Hyperthermia, cisplatin and radiation trimodality treatment: a promising cancer treatment? A review from preclinical studies to clinical application. Int J Hyperthermia. 23:329–341.
  • Bergs JW, Krawczyk PM, Borovski T, ten Cate R, Rodermond HM, Stap J, Medema JP, Haveman J, Essers J, van Bree C, et al. 2013. Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joining. DNA Repair (Amst). 12:38–45.
  • Bergs JW, Franken NAP, ten Cate R, Van Bree C, Haveman J. 2006. Effects of cisplatin and gamma-irradiation on cell survival, the induction of chromosomal aberrations and apoptosis in SW-1573 cells. Mutat Res. 594:148–154.
  • Franken NA, Barendsen GW. 2014. Enhancement of radiation effectiveness by hyperthermia and incorporation of halogenated pyrimidines at low radiation doses as compared with high doses: implications for mechanisms. Int J Radiat Biol. 90:313–317.
  • Franken NA, Oei AL, Kok HP, Rodermond HM, Sminia P, Crezee J, Stalpers LJ, Barendsen GW. 2013. Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (Review). Int J Oncol. 42:1501–1515.
  • Franken NA, Ruurs P, Ludwików G, van Bree C, Kipp JB, Darroudi F, Barendsen GW. 1999. Correlation between cell reproductive death and chromosome aberrations assessed by FISH for low and high doses of radiation and sensitization by iodo-deoxyuridine in human SW-1573 cells. Int J Radiat Biol. 75:293–299.
  • Franken NA, Van Bree C, Veltmaat MA, Rodermond HM, Haveman J, Barendsen GW. 2001. Radiosensitization by bromodeoxyuridine and hyperthermia: analysis of linear and quadratic parameters of radiation survival curves of two human tumor cell lines. J Radiat Res. 42:179–190.
  • Franken NA, Van Bree CV, Kipp JB, Barendsen GW. 1997. Modification of potentially lethal damage in irradiated Chinese hamster V79 cells after incorporation of halogenated pyrimidines. Int J Radiat Biol. 72:101–109.
  • Franken NAP, Rodermond HM, Stap J, Haveman J, van Bree C. 2006. Clonogenic assay of cells in vitro. Nat Protoc. 1:2315–2319.
  • Franken NAP, ten Cate R, Krawczyk PM, Stap J, Haveman J, Aten J, Barendsen GW. 2011. Comparison of RBE values of high-LET α-particles for the induction of DNA-DSBs, chromosome aberrations and cell reproductive death. Radiat Oncol. 6:64.
  • Horsman MR, Overgaard J. 2007. Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol. 19:418–426.
  • Kok HP, Crezee J, Franken NA, Stalpers LJ, Barendsen GW, Bel A. 2014. Quantifying the combined effect of radiation therapy and hyperthermia in terms of equivalent dose distributions. Int J Radiat Oncol Biol Phys. 88:739–745.
  • Krawczyk PM, Borovski T, Stap J, Cijsouw T, ten Cate R, Medema JP, Kanaar R, Franken NA, Aten JA. 2012. Chromatin mobility is increased at sites of DNA double-strand breaks. J Cell Sci. 125:2127–3213.
  • Krawczyk PM, Eppink B, Essers J, Stap J, Rodermond H, Odijk H, Zelensky A, van Bree C, Stalpers LJ, Buist MR, et al. 2011. Temperature-controlled induction of BRCA2 degradation and homologous recombination deficiency sensitizes cancer cells to PARP-1 inhibition. Proc Natl Acad Sci USA. 108: 9851–9856.
  • Myint WK, Ng C, Raaphorst P. 2002. Examining the non-homologous repair process following cisplatin and radiation treatments. Int J Radiat Biol. 78:417–424.
  • Oei AL, Vriend LE, Crezee J, Franken NA, Krawczyk PM. 2015. Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. Radiat Oncol. 10:165.
  • Rabik CA, Dolan ME. 2007. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treatment Rev. 33:9–23.
  • Turchi JJ, Henkels KM, Zhou Y. 2000. Cisplatin-DNA adducts inhibit translocation of the Ku subunits of DNA-PK. Nucl Acids Res. 28:4634–4641.
  • Van Bree C, Franken NA, Bakker PJ, Klomp-Tukker LJ, Barendsen GW, Kipp JB. 1997. Hyperthermia and incorporation of halogenated pyrimidines: radiosensitization in cultured rodent and human tumor cells. Int J Radiat Oncol Biol Phys. 39:489–496.
  • Wilkins DE, Heller DP, Raaphorst GP. 1993. Inhibition of potentially lethal damage recovery by cisplatin in a brain tumor cell line. Anticancer Res. 13:2137–2142.